The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation
Clinical trial NCT03887377 · COMPLETED
Trial details
- NCT number
- NCT03887377
- Sponsor
- Henry Ford Health System
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2024-12-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.